The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase (Ph) II study of the efficacy and safety of the cMET inhibitor capmatinib (INC280) in patients (pts) with advanced hepatocellular carcinoma (HCC).
 
Tawesak Tanwandee
No Relationships to Disclose
 
Wattana Sukeepaisarnjaroen
No Relationships to Disclose
 
Stephen Lam Chan
Consulting or Advisory Role - MedImmune; Novartis
 
SuPin Choo
Honoraria - Bristol-Myers Squibb; Lilly; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Novartis
Travel, Accommodations, Expenses - Merck
 
Guohong Han
No Relationships to Disclose
 
Virote Sriuranpong
Consulting or Advisory Role - Novartis
Research Funding - Novartis
 
Hongming Pan
No Relationships to Disclose
 
Thomas Cheung Yau
No Relationships to Disclose
 
Zhenggang Ren
No Relationships to Disclose
 
Jian-Ming Xu
No Relationships to Disclose
 
Bin Peng
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Takami Saji
Employment - Novartis
Travel, Accommodations, Expenses - Novartis
 
Yongjian Sun
Employment - Johnson & Johnson; Novartis
 
Alan Huang
Employment - Novartis
 
Luigi Manenti
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Travel, Accommodations, Expenses - Novartis
 
Shukui Qin
No Relationships to Disclose